Physician

Alex Garhoe Yip, M.D.

According to 2025 Medicare claims, Alex Yip, M.D. (NPI: 1316937477) practices allergy/immunology in the Wilmington, NC market, with the plurality of this provider's patient population coming from New Hanover, NC. This provider's primary affiliated billing organization is ALLERGY PARTNERS, PLLC (NPI: 1831189992; TIN: 561249571) and primary practice location at 28405-8308. Yip is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Yip's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 343 traditional Medicare patients, billed 5,404 HCPCS/CPT codes, and received $102,924 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 574 prescription claims across 116 beneficiaries totaling $66,240 in drug costs, led by Breo Ellipta (Fluticasone/Vilanterol). DME data shows 25 claims. Open Payments data shows 50 records totaling $1,409. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $47,930 to $102,924. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $237 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	414	4,736	$47,930
2016	429	4,696	$47,461
2017	393	3,531	$38,670
2018	410	3,991	$40,004
2019	429	4,039	$41,376
2020	397	3,080	$34,873
2021	379	4,279	$56,723
2022	362	3,943	$70,530
2023	374	5,328	$105,049
2024	343	5,404	$102,924

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	124	600	$64,060
2016	138	644	$69,902
2017	116	636	$67,707
2018	103	551	$81,793
2019	108	523	$86,995
2020	117	597	$97,088
2021	96	506	$104,965
2022	98	472	$99,234
2023	99	514	$96,959
2024	116	574	$66,240

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	25	$31,194
2017	N/R	25	$31,961
2018	N/R	25	$31,623
2019	N/R	44	$34,905
2020	N/R	25	$33,513
2021	N/R	25	$36,720
2022	N/R	22	$30,935
2023	N/R	26	$36,715
2024	N/R	25	$36,358

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	71	78	$57
95165	Professional service for preparation and provision of 1 or more antigens	50	625	$10
96372	Injection of drug or substance under skin or into muscle	12	36	$9
95117	Professional service for multiple injections of allergen	209	852	$8
95115	Professional service for single injection of allergen	88	413	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Breo Ellipta	Fluticasone/Vilanterol	29	1,410	$17,712
Symbicort	Budesonide/Formoterol Fumarate	24	1,020	$7,354
Wixela Inhub	Fluticasone Propion/Salmeterol	25	1,110	$5,062
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	930	$3,433
Azelastine-Fluticasone	Azelastine/Fluticasone	12	420	$1,708

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	13	$32,402
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	12	$3,956

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	50	$1,409	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alex Garhoe Yip, M.D.?

Tedicare shows public-source Medicare data for Alex Garhoe Yip, M.D. (NPI 1316937477), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alex Garhoe Yip, M.D. have ACO affiliation data?

Alex Garhoe Yip, M.D. is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Alex Garhoe Yip, M.D.?

Alex Garhoe Yip, M.D. is linked to ALLERGY PARTNERS, PLLC (billing NPI 1831189992) in the available physician profile data.

Does Alex Garhoe Yip, M.D. have Open Payments data?

Alex Garhoe Yip, M.D. has 50 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.